Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$MED Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.28 down -221.74% YoY • Reported revenue of $76.38M down -27.64% YoY • Medifast expects third quarter 2026 revenue of $60 million to $80 million, with a loss per share of $0.15 to $0.65, and full year 2026 revenue of $270 million to $300 million.

Price since post

Full Details

Advertisement|Remove ads.